Healthcare | June 09, 2026
DENSTAR project launched to fast-track dengue vaccine licensure in Africa
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The clinical trial will be conducted at 19 sites with 10,335 participants across India
Indonesia national agency for drug and food control, BPOM, approved QDENGA for use in individuals 6 to 45 years of age
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Subscribe To Our Newsletter & Stay Updated
